Skip to main content
Premium Trial:

Request an Annual Quote

FDA Issues EUAs for Detectachem, Optolane Technologies Coronavirus Tests, Color Collection Kit

NEW YORK — The US Food and Drug Administration on Tuesday granted separate Emergency Use Authorizations for molecular SARS-CoV-2 tests developed by Detectachem and Optolane Technologies, as well as a nasal swab self-collection kit from Color.

Detectachem's MobileDetect Bio BCC19 Test Kit uses reverse transcription loop-mediated isothermal nucleic acid amplification to detect the N and E genes of SARS-CoV-2 in nasopharyngeal, anterior nasal, mid-turbinate nasal, and oropharyngeal swab specimens.

It can be used with a variety of thermo cyclers including the Stafford, Texas-based company's MD-Bio Heater, Bio-Rad Laboratories' T100, Benchmark Scientific's TC-32 Mini, Techne's 5Prime/02, Edvotek's EdvoCycler 2 and EdvoCycler Jr., and Thermo Fisher Scientific's Applied Biosystems Veriti and Applied Biosystems MiniAmp.

Optolane's Kaira 2019-nCoV Detection Kit is designed to detect the SARS-CoV-2 E and RdRp genes in nasopharyngeal, oropharyngeal, anterior nasal, and mid-turbinate nasal swab specimens, as well as nasopharyngeal wash/aspirate, nasal aspirate, sputum, and bronchoalveolar lavage specimens.

Nucleic acid extraction is performed using Qiagen's automated QIAsymphony SP instrument and QIAsymphony DSP Virus/Pathogen Mini Kit, according to South Korea-based Optolane. The test can run on Thermo Fisher's Applied Biosystems QuantStudio 5 RT-PCR System or Applied Biosystems 7500 RT-PCR System, or Bio-Rad's CFX96 RT-PCR System.

Both tests may be used by any lab CLIA-certified to perform high-complexity tests, the FDA said.

Color's COVID-19 Test Unmonitored Collection Kit is designed for the unmonitored self-collection of nasal swab specimens at home or in a healthcare setting. Samples may be used with the Burlingame, California-based company's authorized SARS-CoV-2 LAMP Diagnostic Assay.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.